1. Odondi RN, Shitsinzi R, Emarah A. Clinical patterns and early outcomes of burn injuries in patients admitted at the Moi Teaching and Referral Hospital in Eldoret, Western Kenya. Heliyon 2020; 6(3): e03629.## [ DOI:10.1016/j.heliyon.2020.e03629] [ PMID] [ ] 2. Tsolakidis S, Freytag DL, Dovern E, Alharbi Z, Kim BS, Houschyar KS, et al. Infections in Burn Patients: A Retrospective View over Seven Years. Medicina 2022; 58(8): 1066.## [ DOI:10.3390/medicina58081066] [ PMID] [ ] 3. Kelly EJ, Oliver MA, Carney BC, Shupp JW. Infection and burn injury. European Burn Journal 2022; 3(1): 165-79.## [ DOI:10.3390/ebj3010014] 4. Cancio LC, Barillo DJ, Kearns RD, Holmes IV JH, Conlon KM, Matherly AF, et al. Guidelines for burn care under austere conditions: surgical and nonsurgical wound management. Journal of Burn Care & Research 2017; 38(4): 203-14.## [ DOI:10.1097/BCR.0000000000000368] [ PMID] 5. Kagan RJ, Peck MD, Ahrenholz DH, Hickerson WL, Holmes J, IV, Korentager R, et al. Surgical Management of the Burn Wound and Use of Skin Substitutes: An Expert Panel White Paper Journal of Burn Care & Research 2013; 34(2): e60-e79.## [ DOI:10.1097/BCR.0b013e31827039a6] [ PMID] 6. Swanson T, Angel D. International wound infection institute wound infection in clinical practice update principles of best practice. Wounds Int 2022; 24(8): 1-59.## 7. Żwierełło W, Piorun K, Skórka-Majewicz M, Maruszewska A, Antoniewski J, Gutowska I. Burns: classification, pathophysiology, and treatment: A review. International journal of molecular sciences. 2023;24(4).## [ DOI:10.3390/ijms24043749] [ PMID] [ ] 8. D'Abbondanza JA, Shahrokhi S. Burn infection and burn sepsis. Surgical Infections 2021; 22(1): 58-64.## [ DOI:10.1089/sur.2020.102] [ PMID] 9. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P & T: A Peer-Reviewed Journal for Formulary Management 2015; 40(4): 277-83.## 10. Serwecińska L. Antimicrobials and antibiotic-resistant bacteria: a risk to the environment and to public health. Water 2020; 12(12): 3313.## [ DOI:10.3390/w12123313] 11. Udy AA, Roberts JA, Lipman J, Blot S. The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics. Advanced Drug Delivery Reviews 2018; 123: 65-74.## [ DOI:10.1016/j.addr.2017.09.019] [ PMID] 12. Ramos G, Cornistein W, Cerino GT, Nacif G. Systemic antimicrobial prophylaxis in burn patients: systematic review. Journal of Hospital Infection 2017; 97(2): 105-14.## [ DOI:10.1016/j.jhin.2017.06.015] [ PMID] 13. Nugraha FF, Mutiara R, Adhikara A. Implementation Model of The use of Prophylactic Antibiotics in Surgical Patients Hospital Type B. Jurnal Health Sains 2023, 4(3): 40-52.## [ DOI:10.46799/jhs.v4i3.859] 14. Lu P, Holden D, Padiglione A, Cleland H. Perioperative antibiotic prophylaxis in Australian burns patients. Australasian Journal of Plastic Surgery 2022; 5: 48-55.## [ DOI:10.34239/ajops.v5n1.286] 15. Thapa P, Bista D, Baidya P, Giri P. Antibiotic utilization pattern in burn patients admitted at tertiary hospital: A retrospective study. MedRxiv 2022; 2022: 19.## [ DOI:10.1101/2022.02.15.22270999] 16. Dépret F, Farny B, Jeanne M, Klouche K, Leclerc T, Nouette-Gaulain K, et al. The A2B trial, antibiotic prophylaxis for excision-graft surgery in burn patients: a multicenter randomized double-blind study. Trials 2020; 21(1): 973.## [ DOI:10.1186/s13063-020-04894-y] [ PMID] [ ] 17. Rahimzadeh G, Gill P, Saeedi M, Ghasemi M, Rokni GR, Rostamkalaei SS, et al. Evaluation of bacteriophage products against burn wound Methicillin-resistant Staphylococcus aureus (MRSA) infections. Wound Medicine 2020; 28: 100182.## [ DOI:10.1016/j.wndm.2020.100182] 18. Alqahtani S, Alhumoud A, Abushomi H, Alsultan A, Balkhi B. Appropriate therapeutic drug monitoring of antibiotics contributed to lower nephrotoxicity. International Journal of Clinical Pharmacology and Therapeutics. 2020;58(2):82.## [ DOI:10.5414/CP203545] [ PMID] 19. Ejike C, Alumanah E, Ezeanyika L, Ngene A, Ojefua E. Antibiotics administration and its possible liver damage. Bio-Research 2008; 6(2): 351-4.## [ DOI:10.4314/br.v6i2.28665] 20. Benoun JM, Labuda JC, McSorley SJ. Collateral damage: detrimental effect of antibiotics on the development of protective immune memory. mBio 2016; 7(6): 10-1128.## [ DOI:10.1128/mBio.01520-16] [ PMID] [ ] 21. Healy DP, Silverman PA, Neely AN, Holder IA, Babcock GF. Effect of antibiotics on polymorphonuclear neutrophil apoptosis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2002: 22(5): 578-85.## [ DOI:10.1592/phco.22.8.578.33217] [ PMID] 22. Labro M, Benna JE, Abdelghaffar H. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. Journal of Antimicrobial Chemotherapy 1993; 31(suppl_C): 51-64.## [ DOI:10.1093/jac/31.suppl_C.51] [ PMID] 23. Gemmell C. Antibiotics and neutrophil function-potential immnnomodulating activities. Journal of Antimicrobial Chemotherapy 1993; 31(suppl_B): 23-33.## [ DOI:10.1093/jac/31.suppl_B.23] [ PMID] 24. Chen G, Fei X, Ling J. The effects of aminoglycoside antibiotics on platelet aggregation and blood coagulation. Clinical and Applied Thrombosis/Hemostasis. 2012;18(5):538-41.## [ DOI:10.1177/1076029611430955] [ PMID] 25. Sunakawa K, Akita H, Iwata S, Sato Y, Oikawa T, Ichihashi Y. Effects of antibiotics on platelet aggregation. Drugs 1988; 35: 205-7.## [ DOI:10.2165/00003495-198800352-00045] [ PMID] 26. Preyer S, Luckhaupt H. Antibiotics and blood coagulation--current references for the ENT physician. Laryngologie Rhinologie Otologie 1987; 66(2): 107-9.## [ DOI:10.1055/s-2007-998612] 27. Mitani M, Umetsu T, Yamanishi T, Otake N. Studies on the ionophorous antibiotics viii. Effects of monovalent and divalent cation ionophores on blood platelets. The Journal of Antibiotics 1977; 30(3): 239-43.## [ DOI:10.7164/antibiotics.30.239] [ PMID] 28. Mašek K, Libánská J, Nosál R, Rašková H. The effect of staphylococcal α-toxin on blood platelets. Naunyn Schmiedebergs Archiv für Pharmakologie: Band 262 Band 263 Band 264 Band 265. 1969:419-27.## [ DOI:10.1007/978-3-662-39718-3_33] 29. Skoll K, Palmetzhofer J, Lummerstorfer M, Anzengruber M, Gabor F, Wirth M. Human serum albumin nanoparticles as a versatile vehicle for targeted delivery of antibiotics to combat bacterial infections. Nanomedicine: Nanotechnology, Biology and Medicine 2023: 50: 102685.## [ DOI:10.1016/j.nano.2023.102685] [ PMID] 30. Seedher N, Agarwal P. Competitive binding of fluoroquinolone antibiotics and some other drugs to human serum albumin: a luminescence spectroscopic study. Luminescence 2013; 28(4): 562-8.## [ DOI:10.1002/bio.2494] [ PMID] 31. Nakamura K, Kageyama S, Ito T, Hirao H, Kadono K, Aziz A, et al. Antibiotic pretreatment alleviates liver transplant damage in mice and humans. The Journal of Clinical Investigation 2019; 129(8): 3420-34.## [ DOI:10.1172/JCI127550] [ PMID] [ ] 32. Strohmeyer G, Weik C. Liver damage caused by drugs. Zeitschrift fur Gastroenterologie 1999; 37(5): 367-78.## 33. Nikolić A, Jaćović S, Mijailović Ž, Petrović D. Basic Principles of antibiotics dosing in patients with sepsis and acute kidney damage treated with continuous venovenous hemodiafiltration. Experimental and Applied Biomedical Research (EABR), 2019.## [ DOI:10.2478/sjecr-2018-0071] 34. Yang X, Zhong H, Xu C, Xu G. Spotlights on Antibiotic-induced acute kidney injury: the evidence to date. Iranian Journal of Kidney Diseases 2019; 13(1): 10-20.## 35. Kovnat P, Labovitz E, Levison SP. Antibiotics and the kidney. Medical Clinics of North America 1973; 57(4): 1045-63.## [ DOI:10.1016/S0025-7125(16)32250-7] [ PMID] 36. Korzeniowski T, Mądry R, Torres K, Kozicka M, Strużyna J. Application Of the enzymatic debridement of burn wounds in patients during the covid-19 epidemic. Annals of Burns and Fire Disasters 2022; 35(2): 132.## 37. Griffin BR, Bairagi A, Holbert M, Kimble RM. Effects of early, non-excisional debridement on pediatric burn wound re-epithelialisation time. Journal of Burn Care & Research 2022; 43(Supplement_1): S56-S7.## [ DOI:10.1093/jbcr/irac012.087] [ ] 38. Ziegler B, Fischer S, Pieper D, Mathes T, Kneser U, Hirche C. Evidence and trends in burn wound debridement: an evidence map. Plastic Surgery 2020; 28(4): 232-42.## [ DOI:10.1177/2292550320928553] [ PMID] [ ] 39. Piatkowski A, Gröger A, Pantel M, Bozkurt A, Fuchs PC, Pallua N. The extent of thermal injury affects fractions of mononuclear cells. Burns 2009; 5(2): 256-63.## [ DOI:10.1016/j.burns.2008.05.017] [ PMID] 40. AL-Watify DGO. Inflammatory cytokines, proteins, and white blood cells in burned patients affected with second and third degree of Burn. Journal of University of Babylon for Pure and Applied Sciences 2018; 26(5): 103-19.## [ DOI:10.29196/jub.v26i5.872] 41. Herndon D, Rutan T, Mlakar J, Fleming D. White cells in burn patients. Host Defense Dysfunction in Trauma, Shock and Sepsis: Mechanisms and Therapeutic Approaches: Springer; 1993; 385-90.## [ DOI:10.1007/978-3-642-77405-8_43] 42. Laggner M, Lingitz MT, Copic D, Direder M, Klas K, Bormann D, et al. Severity of thermal burn injury is associated with systemic neutrophil activation. Scientific Reports 2022; 12(1): 1654.## [ DOI:10.1038/s41598-022-05768-w] [ PMID] [ ] 43. Zhang F, Qiu XC, Wang JJ, Hong XD, Wang GY, Xia ZF. Burn-related dysregulation of inflammation and immunity in experimental and clinical studies. Journal of Burn Care & Research 2017; 38(6): e892-e9.## [ DOI:10.1097/BCR.0000000000000511] [ PMID] 44. Balogh D, Lammer H, Kornberger E, Stuffer M, Schönitzer D. Neopterin plasma levels in burn patients. Burns 1992; 18(3): 185-8.## [ DOI:10.1016/0305-4179(92)90068-6] [ PMID] 45. Osman OF. Early and late immunological changes in burn patients. In The Management of Mass Burn Casualties and Fire Disasters: Proceedings of the First International Conference on Burns and Fire Disasters 1992; 285-7. ## [ DOI:10.1007/978-0-585-33973-3_53] 46. Matondang AIS, Paramita DA. The association between the extend of burn injuries with albumin level on burn injury patients. Sumatera Medical Journal 2020; 3(2); 1-6.## [ DOI:10.32734/sumej.v3i2.3601] 47. Megahed M, El-Helbawy R, Gad S, Mansour M, Elkandary K. Base deficit, serum albumin level and blood haemoglobin concentration can be used as predictor factors for mortality in major burn patients. Annals of Burns and Fire Disasters 2020; 33(3): 209.## 48. Aguayo-Becerra OA, Torres-Garibay C, Macías-Amezcua MD, Fuentes-Orozco C, Chávez-Tostado MdG, Andalón-Dueñas E, et al. Serum albumin level as a risk factor for mortality in burn patients. Clinics 2013; 68: 940-5.## [ DOI:10.6061/clinics/2013(07)09] [ PMID] |
